Alliancebernstein L.P. Sana Biotechnology, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 170,075 shares of SANA stock, worth $273,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares

170,075

Previous 170,075 -0.0%

Holding current value

$273,820

Previous $928,000 23.81%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.23 - $10.44 $234,042 - $467,190	44,750 Added 35.71%	170,075 $928,000
Q1 2024 May 14, 2024	SELL	$4.2 - $11.27 $5,334 - $14,312	-1,270 Reduced 1.0%	125,325 $1.25 Million
Q2 2023 Aug 15, 2023	BUY	$3.22 - $7.53 $32,844 - $76,806	10,200 Added 8.76%	126,595 $754,000
Q1 2023 May 15, 2023	BUY	$3.11 - $4.92 $27,368 - $43,296	8,800 Added 8.18%	116,395 $380,000
Q2 2022 Aug 15, 2022	BUY	$4.12 - $9.35 $12,767 - $28,975	3,099 Added 2.97%	107,595 $692,000
Q1 2022 May 13, 2022	BUY	$5.24 - $15.58 $1,048 - $3,116	200 Added 0.19%	104,496 $863,000
Q4 2021 Feb 14, 2022	BUY	$15.18 - $23.15 $19,734 - $30,094	1,300 Added 1.26%	104,296 $1.62 Million
Q3 2021 Nov 10, 2021	BUY	$16.29 - $25.88 $1.2 Million - $1.9 Million	73,500 Added 249.19%	102,996 $2.32 Million
Q2 2021 Jul 30, 2021	BUY	$16.65 - $32.14 $262,520 - $506,751	15,767 Added 114.84%	29,496 $580,000
Q1 2021 May 06, 2021	BUY	$23.04 - $43.5 $316,316 - $597,211	13,729 New	13,729 $460,000

Others Institutions Holding SANA

# of Institutions

174

Shares Held

121M

Call Options Held

1.87M

Put Options Held

1.48M

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $306M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Sana Biotechnology, Inc. Transaction History